• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多腔导管中同时输注不相容药物的体外研究。

In vitro study of simultaneous infusion of incompatible drugs in multilumen catheters.

作者信息

Collins J L, Lutz R J

机构信息

Clinical Center, National Institutes of Health, Bethesda, MD 20892.

出版信息

Heart Lung. 1991 May;20(3):271-7.

PMID:1903369
Abstract

Multilumen catheters are commonly used to simultaneously administer incompatible drugs to critically ill patients. Though there are no known documented reports that this practice has been responsible for harmful events in patients, likewise there are no published data to verify the safety and efficacy of this practice. This study utilized an in vitro model flow system to examine the physicochemical phenomena that occur when two incompatible drugs (phenytoin and total parenteral nutrition) are simultaneously administered through multilumen catheters. Flow conditions and drug infusions in the venous model were designed to mimic the in vivo clinical situation to evaluate two central venous catheter types, a double- and a triple-lumen catheter. Video recordings were made of drug interactions, and assays of phenytoin concentration were performed on samples of the circulating fluid. White clouds of phenytoin precipitation were observed near the tip of the double-lumen catheter but not the triple-lumen catheter. Infusion through the double-lumen catheter resulted in an average of 6% loss of phenytoin to precipitate, which, on microscopic examination, appeared as spindle-shaped crystals 25 to 50 microns in length and 5 to 10 microns wide. In some cases, millimeter-size fragments of phenytoin precipitate were seen to dislodge from the tip of the double-lumen catheter. The adjacent orifices at the tip of the end hole of the double-lumen catheter appeared to permit interaction of the two effusing streams of the incompatible drugs, whereas the staggered orifices of the triple-lumen catheter reduce this interaction.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

多腔导管常用于同时为重症患者输注不相容的药物。尽管尚无已知的文献报道这种做法会导致患者出现有害事件,但同样也没有已发表的数据来证实这种做法的安全性和有效性。本研究利用体外模型流动系统,来研究当两种不相容药物(苯妥英和全胃肠外营养)通过多腔导管同时输注时所发生的物理化学现象。静脉模型中的流动条件和药物输注设计为模拟体内临床情况,以评估两种中心静脉导管类型,即双腔导管和三腔导管。对药物相互作用进行了视频记录,并对循环液样本进行了苯妥英浓度测定。在双腔导管尖端附近观察到了苯妥英沉淀的白色云雾,但在三腔导管中未观察到。通过双腔导管输注导致平均6%的苯妥英沉淀损失,经显微镜检查,沉淀呈现为长度25至50微米、宽度5至10微米的纺锤形晶体。在某些情况下,可见毫米大小的苯妥英沉淀碎片从双腔导管尖端脱落。双腔导管末端孔尖端相邻的孔口似乎允许不相容药物的两股流出液相互作用,而三腔导管交错排列的孔口则减少了这种相互作用。(摘要截取自250字)

相似文献

1
In vitro study of simultaneous infusion of incompatible drugs in multilumen catheters.多腔导管中同时输注不相容药物的体外研究。
Heart Lung. 1991 May;20(3):271-7.
2
Triple- vs single-lumen central venous catheters. A prospective study in a critically ill population.三腔与单腔中心静脉导管。对危重症人群的一项前瞻性研究。
Arch Intern Med. 1989 May;149(5):1139-43.
3
Rates of infection for single-lumen versus multilumen central venous catheters: a meta-analysis.单腔与多腔中心静脉导管的感染率:一项荟萃分析。
Crit Care Med. 2003 Sep;31(9):2385-90. doi: 10.1097/01.CCM.0000084843.31852.01.
4
In vivo evaluation of simultaneous administration of incompatible drugs via a double-lumen peripheral catheter.通过双腔外周导管同时给予不相容药物的体内评估。
Crit Care Med. 1990 Oct;18(10):1164-6. doi: 10.1097/00003246-199010000-00022.
5
[Use of peripherally inserted multilumen catheters as an alternative to central venous access].[使用外周插入多腔导管作为中心静脉通路的替代方法]
An Esp Pediatr. 2002 Jul;57(1):18-21.
6
An analysis of drug delivery dynamics via a pediatric central venous infusion system: quantification of delays in achieving intended doses.通过儿科中心静脉输液系统的药物输送动力学分析:实现预期剂量的延迟量化
Anesth Analg. 2009 Oct;109(4):1156-61. doi: 10.1213/ane.0b013e3181b220c9.
7
Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis.抗菌粘结未能预防中心静脉导管相关感染和败血症。
Am Surg. 1996 Aug;62(8):641-6.
8
Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients.危重症患者中银浸渍多腔中心静脉导管与标准多腔中心静脉导管的比较。
Crit Care Med. 2007 Apr;35(4):1032-9. doi: 10.1097/01.CCM.0000259378.53166.1B.
9
In-vivo evaluation of simultaneous administration of incompatible drugs in a central venous catheter with a decreased port to port distance.在中心静脉导管中端口间距减小情况下同时给予不相容药物的体内评估。
Crit Care. 1999;3(1):51-53. doi: 10.1186/cc307.
10
Tunneled infusion catheter breakage: frequency and repair kit outcomes.
J Vasc Interv Radiol. 2008 Feb;19(2 Pt 1):201-6. doi: 10.1016/j.jvir.2007.08.030.

引用本文的文献

1
Physicochemical stability of mixtures of non-steroidal anti-inflammatory drugs such as ketorolac and diclofenac and antiemetics such as ondansetron and ramosetron: an study.酮咯酸和双氯芬酸等非甾体抗炎药与昂丹司琼和雷莫司琼等止吐药混合物的物理化学稳定性:一项研究。
Korean J Pain. 2025 Apr 1;38(2):103-115. doi: 10.3344/kjp.24316.
2
Optimising an Infusion Protocol Containing Cefepime to Limit Particulate Load to Newborns in a Neonatal Intensive Care Unit.优化含头孢吡肟的输注方案以限制新生儿重症监护病房中新生儿的微粒负荷
Pharmaceutics. 2021 Mar 8;13(3):351. doi: 10.3390/pharmaceutics13030351.
3
Strategies to prevent drug incompatibility during simultaneous multi-drug infusion in intensive care units: a literature review.
策略以防止药物不相容性在重症监护病房同时多药物输注期间:文献回顾。
Eur J Clin Pharmacol. 2021 Sep;77(9):1309-1321. doi: 10.1007/s00228-021-03112-1. Epub 2021 Mar 25.
4
Intravenous Drug Incompatibilities in the Intensive Care Unit of a Tertiary Care Hospital in India: Are they Preventable?印度一家三级护理医院重症监护病房中的静脉药物配伍禁忌:它们可预防吗?
J Res Pharm Pract. 2020 Jun 26;9(2):106-111. doi: 10.4103/jrpp.JRPP_20_11. eCollection 2020 Apr-Jun.
5
Variables decreasing tip movement of peripherally inserted central catheters in pediatric patients.减少儿科患者外周静脉穿刺中心静脉导管尖端移动的变量。
Pediatr Radiol. 2016 Oct;46(11):1532-8. doi: 10.1007/s00247-016-3648-1. Epub 2016 Jun 7.
6
In-vivo evaluation of simultaneous administration of incompatible drugs in a central venous catheter with a decreased port to port distance.在中心静脉导管中端口间距减小情况下同时给予不相容药物的体内评估。
Crit Care. 1999;3(1):51-53. doi: 10.1186/cc307.